{"id":950042,"date":"2026-04-08T17:03:51","date_gmt":"2026-04-08T21:03:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/"},"modified":"2026-04-08T17:03:51","modified_gmt":"2026-04-08T21:03:51","slug":"aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/","title":{"rendered":"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution"},"content":{"rendered":"<h2>\nDigital solution\u00a0will be designed to help\u00a0guide\u00a0users\u00a0through\u00a0injection\u00a0process<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>CINCINNATI, April  08, 2026  (GLOBE NEWSWIRE) &#8212; Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (\u201cEnable\u201d), a healthcare innovation company developing and manufacturing the enFuse<sup>\u00ae<\/sup>\u00a0On-Body\u00a0Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable\u2019s preferred digital health partner for the\u00a0enFuse<sup>\u00ae<\/sup>\u00a0system.\u00a0This digital solution will\u00a0be designed to\u00a0guide patients and caregivers throughout the injection process and\u00a0help\u00a0strengthen engagement support before, during and after administration.\u00a0<\/p>\n<p>Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections\u2019\u00a0enFuse<sup>\u00ae<\/sup>\u00a0system, designed to enhance\u00a0the\u00a0patient experience and support adherence. Key features\u00a0of the solution\u00a0will\u00a0include treatment data recording, onboarding and training modules, injection guidance, patient-reported\u00a0outcomes\u00a0and symptom tracking\u00a0&#8211;\u00a0helping\u00a0to\u00a0empower patients and caregivers with greater confidence and control over the treatment\u00a0process.\u00a0<\/p>\n<p>Built on a flexible and scalable architecture, the companion solution will be deployed alongside the\u00a0enFuse<sup>\u00ae<\/sup> system, enabling pharmaceutical partners to extend the value of their therapies beyond delivery. Designed to evolve across the drug development lifecycle, the solution will support use cases from clinical trials through commercialization, aligned with development and launch strategies.<\/p>\n<p>Adherence data and patient reported outcomes\u00a0will be\u00a0captured\u00a0remotely,\u00a0securely stored and made available through analytics dashboards that generate actionable insights to support clinical development, launch readiness and real-world use. The modular, program-specific design\u00a0will\u00a0allow pharmaceutical partners to integrate digital components into their clinical or commercial programs based on their needs. By combining device-generated data with patient reported insights, the solution will\u00a0help\u00a0drive more informed decisions grounded in real-world usage.\u00a0<\/p>\n<p>\u201cThe\u00a0enFuse<sup>\u00ae<\/sup>\u00a0companion solution reflects our vision of a more connected treatment experience that supports patients beyond the moment of injection,\u201d said Michael D. Hooven,\u00a0Chairman\u00a0and CEO of Enable Injections. \u201cTogether with Aptar Digital Health, we aim to combine innovative drug delivery with digital support tools that can help patients remain engaged in their therapy and enable healthcare providers to better understand and support each patient\u2019s journey.\u201d\u00a0<\/p>\n<p>\u201cWe are excited to partner with Enable Injections to help bring the next generation of drug delivery solutions to life,\u201d said Damien McKeon, SVP Strategic Partnerships, Aptar Digital Health. \u201cLarge-volume biologic therapies are increasingly used to treat complex chronic conditions. They often require long-term adherence to achieve optimal outcomes. Digital solutions supporting treatment tracking and patient engagement can help address common adherence challenges associated with self-administration.\u201d<\/p>\n<p>\n        <strong>About Aptar\u00a0Digital Health<\/strong>\u00a0<br \/>Aptar Pharma&#8217;s Digital Health division is part of AptarGroup, Inc.\u00a0(NYSE:ATR),\u00a0a global leader in drug delivery, including dosing and protection technologies, and consumer product dispensing. Aptar Digital Health creates end-to-end solutions to enhance patient experiences every day,\u00a0leveraging\u00a0a holistic ecosystem of digital interventions. Amplified by an industry-leading portfolio of products and solutions, Aptar Digital Health\u2019s offering combines mobile and web apps, Software-as-Medical-Device, connected drug delivery systems, advanced data analysis services, and patient onboarding and training solutions to actively empower patients and create a positive treatment journey. Headquartered in Crystal Lake, Illinois, Aptar employs 14,000 dedicated people across 20 countries. Learn more at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2u4B-MuFXYVm_2yfUsQjHSOFE-vDKE1kizbkHHVOVdfYgr2LYl8cVR9fJ1heO4SN5MhOa-enu4nSHUKS3JPTKTY2l8Wgp1pFSoDPqHLeedgGwsvfl8xL_sjlDBSUOKQE\" rel=\"nofollow\" target=\"_blank\">www.aptardigitalhealth.com<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0je20Kn2QJBwxNp8msm6miHn7ZiNNL0MqdBuPOY6u5oE6g2bx-wU6bR-NTP_pXcCVLEI0Dy4mEWdUVJTs_1G-0e24g3CQnWWjj3aA3lprvM=\" rel=\"nofollow\" target=\"_blank\">http:\/\/www.aptar.com<\/a>.<\/p>\n<p>\n        <strong>About Enable Injections<\/strong><br \/>\n        <br \/>Cincinnati-based Enable Injections is a global healthcare innovation company committed to improving the patient treatment experience through the development and manufacturing of the\u00a0enFuse<sup>\u00ae<\/sup>\u00a0on-body drug delivery system. An innovative wearable technology, the\u00a0enFuse<sup>\u00ae\u00a0<\/sup>system is designed to deliver large volumes of pharmaceutical and biologic therapeutics via subcutaneous administration, with the aim of improving convenience, supporting improved outcomes, and advancing healthcare system economics.<\/p>\n<p>Enable is currently working with\u00a0a number of\u00a0pharmaceutical partners to conduct clinical trials and plan for\u00a0the\u00a0joint commercial launch of their therapies in combination with the\u00a0enFuse<sup>\u00ae<\/sup>\u00a0technology. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EsSDlcAomhVuR1qYI0Ly4I_XQbh6HqgZQzP3c1hL7hvgBFpCEumvTvW35rc3vVvvG6VoVrkvioCmjw1BYE3Bkk7t8Y7m4baijcujfBE-qu4xI_2-Ic1QVywbvrAKCnuT\" rel=\"nofollow\" target=\"_blank\">www.enableinjections.com<\/a>.<\/p>\n<p>\n        <strong>Media Contacts:<\/strong>\u00a0<br \/>Ciara Jackson\u00a0<br \/>Aptar Pharma<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=H-GGriAi3VnmNRVsIqLHB2akCdB6sYSMj55xMrAJSpBCQApSFofuFmi3pRDCY2i_dnZn_LnDxCOXrIbjgYx-wr94aGmkpARPvHbdxNt03aO5HKT_zO4P-VPYm-kMjHC2\" rel=\"nofollow\" target=\"_blank\">ciara.jackson@aptar.com<\/a><\/p>\n<p>Robert Haney<br \/>Real Chemistry <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5Mw_qfwj3eQdzJ-R7AXSkxLtX9Xl3aEkEapT_Mg8fcrj9I4QJtliWdovygVwV0dLk6NS_44usy0UqtGDWVHzSSrXtNhB6lnyXrjlLcme0C5nycwCMe1r-toyX58axSRH\" rel=\"nofollow\" target=\"_blank\">rhaney@realchemistry.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGJlNjJiNGMtMmUzMi00ZjkyLTk1NWUtMGNmNTBjYWQ4OTc0LTEzMDE3MjAtMjAyNi0wNC0wOC1lbg==\/tiny\/Enable-Injections-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Digital solution\u00a0will be designed to help\u00a0guide\u00a0users\u00a0through\u00a0injection\u00a0process CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) &#8212; Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (\u201cEnable\u201d), a healthcare innovation company developing and manufacturing the enFuse\u00ae\u00a0On-Body\u00a0Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable\u2019s preferred digital health partner for the\u00a0enFuse\u00ae\u00a0system.\u00a0This digital solution will\u00a0be designed to\u00a0guide patients and caregivers throughout the injection process and\u00a0help\u00a0strengthen engagement support before, during and after administration.\u00a0 Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections\u2019\u00a0enFuse\u00ae\u00a0system, designed to enhance\u00a0the\u00a0patient experience and support adherence. Key features\u00a0of the solution\u00a0will\u00a0include treatment data recording, onboarding and training modules, injection guidance, patient-reported\u00a0outcomes\u00a0and symptom tracking\u00a0&#8211;\u00a0helping\u00a0to\u00a0empower patients and caregivers &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-950042","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Digital solution\u00a0will be designed to help\u00a0guide\u00a0users\u00a0through\u00a0injection\u00a0process CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) &#8212; Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (\u201cEnable\u201d), a healthcare innovation company developing and manufacturing the enFuse\u00ae\u00a0On-Body\u00a0Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable\u2019s preferred digital health partner for the\u00a0enFuse\u00ae\u00a0system.\u00a0This digital solution will\u00a0be designed to\u00a0guide patients and caregivers throughout the injection process and\u00a0help\u00a0strengthen engagement support before, during and after administration.\u00a0 Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections\u2019\u00a0enFuse\u00ae\u00a0system, designed to enhance\u00a0the\u00a0patient experience and support adherence. Key features\u00a0of the solution\u00a0will\u00a0include treatment data recording, onboarding and training modules, injection guidance, patient-reported\u00a0outcomes\u00a0and symptom tracking\u00a0&#8211;\u00a0helping\u00a0to\u00a0empower patients and caregivers &hellip; Continue reading &quot;Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-08T21:03:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution\",\"datePublished\":\"2026-04-08T21:03:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/\"},\"wordCount\":665,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/\",\"name\":\"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=\",\"datePublished\":\"2026-04-08T21:03:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/","og_locale":"en_US","og_type":"article","og_title":"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution - Market Newsdesk","og_description":"Digital solution\u00a0will be designed to help\u00a0guide\u00a0users\u00a0through\u00a0injection\u00a0process CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) &#8212; Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (\u201cEnable\u201d), a healthcare innovation company developing and manufacturing the enFuse\u00ae\u00a0On-Body\u00a0Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable\u2019s preferred digital health partner for the\u00a0enFuse\u00ae\u00a0system.\u00a0This digital solution will\u00a0be designed to\u00a0guide patients and caregivers throughout the injection process and\u00a0help\u00a0strengthen engagement support before, during and after administration.\u00a0 Through this partnership, Aptar Digital Health will deliver a companion digital solution for Enable Injections\u2019\u00a0enFuse\u00ae\u00a0system, designed to enhance\u00a0the\u00a0patient experience and support adherence. Key features\u00a0of the solution\u00a0will\u00a0include treatment data recording, onboarding and training modules, injection guidance, patient-reported\u00a0outcomes\u00a0and symptom tracking\u00a0&#8211;\u00a0helping\u00a0to\u00a0empower patients and caregivers &hellip; Continue reading \"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-08T21:03:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution","datePublished":"2026-04-08T21:03:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/"},"wordCount":665,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/","name":"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=","datePublished":"2026-04-08T21:03:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY4NjM3NyM3NTI1OTg1IzIyOTAxNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aptar-digital-health-partners-with-enable-injections-for-enfuse-companion-digital-solution-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aptar Digital Health\u00a0Partners with\u00a0Enable Injections\u00a0for\u00a0enFuse\u00ae\u00a0Companion Digital Solution"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950042","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=950042"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/950042\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=950042"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=950042"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=950042"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}